𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P.8.a.014 Milnacipran for the treatment of fibromyalgia syndrome: a european multicenter, double-blind, placebo-controlled trial

✍ Scribed by J. Branco; G. Bragee; O. Zachrisson; K. Mikkelsen; L. De Teresa; Y. Mainguy; M. Galissié; S. Lugardon; N. Pezous

Book ID
118595320
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
69 KB
Volume
18
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind placebo-controlled trial
A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
✍ Olivier Vitton; Michael Gendreau; Judy Gendreau; Jay Kranzler; Srinivas G. Rao 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Fibromyalgia syndrome is a systemic disorder of widespread pain which is thought to result from abnormal pain processing within the central nervous system. There are no currently approved treatments for this indication. Antidepressants appear, however, to be effective, especially those with an actio

Gabapentin in the treatment of fibromyal
Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial
✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin